ArticleBMC biology2025
annATAC: automatic cell type annotation for scATAC-seq data based on language model.
Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cell type annotation for scATAC-seq via DNA large language model and graph domain adaptation.PLoS computational biology · 2026Article
- Clustering single-cell multi-omics data via multi-subspace contrastive learning with structural smoothness.Briefings in bioinformatics · 2026Article
- Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCell type annotation serves as the cornerstone for downstream analysis of single cell data. Nevertheless, scATAC-seq data is characterized by high sparsity and dimensionality, presenting significant challenges to its annotation process.
resultsWe introduce a novel method based on language model, named annATAC, which is designed for the automatic annotation of cell types in scATAC-seq data. This method primarily consists of three stages. During the pre-training stage, by training on a vast amount of unlabeled data, the model can learn the interaction relationships between peaks, thus building a preliminary understanding of the data features. Subsequently, in the fine-tuning stage, a small quantity of labeled data is utilized to conduct secondary training on the model, which enables the model to identify cell types accurately. Finally, in the prediction stage, the trained model is applied to annotate scATAC-seq data.
conclusionsCompared with other automatic annotation methods across multiple datasets, annATAC demonstrates superiority on the annotation performance. Further experiments have validated that annATAC holds great potential in identifying marker peaks and marker motifs. It is expected that annATAC will provide more profound and precise analysis outcomes for scATAC-seq research. As a result, it will effectively promote the progress of relevant biomedical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.